We pull on expertise from world class access experts to offer realistic and actionable evidence advice to future proof your asset across major markets.
Payers, including HTA agencies, reimbursement and coverage bodies, and pricing authorities, now have a dominant role in every major pharmaceutical market, so it's essential to meet the ‘payer bar’.
Access InVivo provides top-tier guidance on all aspects of market access.
How We Are Different
-
Our team includes globally recognised thought leaders with deep real-world experience in decision making roles. We bring the best access expertise to help you succeed. Learn more About Us.
-
Our materials help you refine your value proposition, while providing information that enables rigorous yet pragmatic expert advice, to drive the best possible patient access.
-
Our model encourages independent thinking and avoids groupthink. We’re honest about fit and timing and if it’s not right, we’ll say so. Our goal is to deliver clear, high-quality, and unbiased advice.
-
We create a safe, risk-free space to develop payer evidence strategy. Grounded in expectations from key launch markets, we deliver integrated recommendations that support global patient access.
-
We help future-proof your evidence plan and ensure readiness for evolving market demands by predicting the healthcare environment that you will need to navigate at launch.
Who We Support
We primarily support biotech and small-to-mid-sized pharma companies, especially those seeking focused, pragmatic advice where resources are limited. If that’s you, we’re here to help.
How We Work
We understand R&D pressures and work responsively to maximise patient access and commercial potential. Many clients engage us ahead of Phase II or III trials, but earlier conversations often yield even greater value.
How We Add Value
Our advice drives effective evidence generation to improve patient access and commercial outcomes, support investment decisions, and enhance partnering opportunities and deal values.